Transplant
26
4
6
13
Key Insights
Highlights
Success Rate
81% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.5%
3 terminated out of 26 trials
81.3%
-5.3% vs benchmark
19%
5 trials in Phase 3/4
23%
3 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (26)
Concomitant Renal and Urinary Bladder Allograft Transplantation
Optimizing Y90 Therapy for Radiation Lobectomy
Simultaneous Prospective Kidney Transplant Assessment in Combined Liver Kidney Candidates
Improving Medication Adherence in Adolescents Who Had a Liver Transplant
OCS Heart Perfusion Post-Approval Registry
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Xofluza-Wearables Feasibility-Study
Donor Outcomes Following Hand-Assisted and Robotic Living Donor Nephrectomy: a Retrospective Review
Improving Transplant Medication Safety Through A Technology and Pharmacist Intervention
Immune Function as Predictor of Infectious Complications and Clinical Outcome in Patients Undergoing Solid Organ Transplantation
Liver Transplantation After ex Vivo Liver Perfusion
The Prospective Evaluation of Pancreatic Function in Pancreas Transplant Recipients
Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient
Cytomegalovirus (CMV) MicroRNA Expression in Vivo and Immune Evasion Correlates
CNTRP POSITIVE Study
PD-1 Antibody for Reactive EBV After BMT
Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients
Effects of Thymoglobulin on Human B Cells
Fertility Study of Women Who Received Organ Transplantation
Safety and Immunogenicity of Human Papillomavirus (HPV) Vaccine in Solid Organ Transplant Recipients